Product Images Cefepime Hydrochloride And Dextrose

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Cefepime Hydrochloride And Dextrose NDC 0264-3193 by B. Braun Medical Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Diagram 1 - cefepime for injection in duplex 1

Diagram 1 - cefepime for injection in duplex 1

cefepime for injection in duplex 10

cefepime for injection in duplex 10

This is a label on a drug chamber packaging. It provides instructions to peel the foil strip only when ready to use and discard the unit if the strip is damaged. It also advises visually inspecting the drug prior to reconstitution and provides a reference to the package insert for complete directions on reconstitution and administration.*

Diagram 2 - cefepime for injection in duplex 2

Diagram 2 - cefepime for injection in duplex 2

Diagram 3 - cefepime for injection in duplex 3

Diagram 3 - cefepime for injection in duplex 3

Diagram 4 - cefepime for injection in duplex 4

Diagram 4 - cefepime for injection in duplex 4

Diagram 5 - cefepime for injection in duplex 5

Diagram 5 - cefepime for injection in duplex 5

Chemical Structure - cefepime for injection in duplex 6

Chemical Structure - cefepime for injection in duplex 6

3193-11 container label - cefepime for injection in duplex 7

3193-11 container label - cefepime for injection in duplex 7

3195-11 container label - cefepime for injection in duplex 8

3195-11 container label - cefepime for injection in duplex 8

This is a description of a medical product. It is a single-dose sterile and nonpyrogenic solution containing Cefepime Hydrochloride USP equivalent to 1 g of cefepime and L-arginine for pH adjustment. This solution is meant for IV use only and comes in a 50 mL Duplex container. The product must be used within 7 days of peeling the foil strip, but not beyond the labeled expiration date. The reconstitution process involves folding the container and squeezing the diluent chamber until the seal opens and releases diluent into the drug chamber, followed by squeezing the container again until the seal between drug chamber and set port opens. The product is not made with natural rubber latex, PVC or DEHP. Further information on reconstitution and administration is available in the package insert of the product.*

Display Panel Drug Barrier Strip - cefepime for injection in duplex 9

Display Panel Drug Barrier Strip - cefepime for injection in duplex 9

Cefepime and Dextrose Injection is a sterile and non-pyrogenic intravenous solution containing Cefepime Hydrochloride USP equivalent to 2g of cefepime with L-arginine for pH adjustment. After reconstitution, each 50 mL single-dose unit contains Cefepime for Injection and approximately 5% w/v of Hydrous Dextrose USP in Water for Injection USP. It is used for the treatment of bacterial infections. The solution must be used within 7 days of sealing the foil strip and it should be protected from light. The solution should be clear and free from particulate matter before use. The complete directions for reconstitution and administration can be found in the package insert. This product is not made with natural rubber latex, FVC, or DEHP. It is recommended to check for minute leaks before administration. The product must be kept between 15-30°C, and it should not be frozen.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.